Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Biphasic Insulin Aspart 50 vs 70 in T2DM
NCT00612599Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2003
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2003; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00612599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612599.